Compounds and compositions as protease inhibitors
US6506733B1 · kind B1 · utility
17Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2000 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Mar 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C317/28
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formula: are provided, and are useful as cysteine protease inhibitors, particularly in the treatment of diseases such as osteoporosis or autoimmune disorders in which cathepsins K or S contribute to the pathology or symptomatolgy of the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.